vs

Side-by-side financial comparison of FIRST BUSINESS FINANCIAL SERVICES, INC. (FBIZ) and Health Catalyst, Inc. (HCAT). Click either name above to swap in a different company.

Health Catalyst, Inc. is the larger business by last-quarter revenue ($74.7M vs $44.3M, roughly 1.7× FIRST BUSINESS FINANCIAL SERVICES, INC.). FIRST BUSINESS FINANCIAL SERVICES, INC. runs the higher net margin — 27.5% vs -121.9%, a 149.4% gap on every dollar of revenue. On growth, FIRST BUSINESS FINANCIAL SERVICES, INC. posted the faster year-over-year revenue change (8.5% vs -6.2%). Over the past eight quarters, FIRST BUSINESS FINANCIAL SERVICES, INC.'s revenue compounded faster (8.0% CAGR vs -0.0%).

The PNC Financial Services Group, Inc. is an American bank holding company and financial services corporation based in Pittsburgh, Pennsylvania. Its banking subsidiary, PNC Bank, operates in 27 states and the District of Columbia, with 2,629 branches and 9,523 ATMs. PNC Bank is one of the largest banks in the US by assets and by number of branches, deposits, and ATMs.

Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company based in Coral Gables, Florida, United States. The company develops medicines for rare diseases, including the phosphate salt of amifampridine for the treatment of Lambert–Eaton myasthenic syndrome (LEMS). The drug is referred to under the trade name Firdapse, which was approved by the FDA for approved use in children 6 years and older with LEMS in addition to the prior approval for use in adults with LEMS on November 28, 2018. Fir...

FBIZ vs HCAT — Head-to-Head

Bigger by revenue
HCAT
HCAT
1.7× larger
HCAT
$74.7M
$44.3M
FBIZ
Growing faster (revenue YoY)
FBIZ
FBIZ
+14.7% gap
FBIZ
8.5%
-6.2%
HCAT
Higher net margin
FBIZ
FBIZ
149.4% more per $
FBIZ
27.5%
-121.9%
HCAT
Faster 2-yr revenue CAGR
FBIZ
FBIZ
Annualised
FBIZ
8.0%
-0.0%
HCAT

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
FBIZ
FBIZ
HCAT
HCAT
Revenue
$44.3M
$74.7M
Net Profit
$12.2M
$-91.0M
Gross Margin
Operating Margin
-115.3%
Net Margin
27.5%
-121.9%
Revenue YoY
8.5%
-6.2%
Net Profit YoY
9.2%
-340.3%
EPS (diluted)
$1.44
$-1.29

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FBIZ
FBIZ
HCAT
HCAT
Q1 26
$44.3M
Q4 25
$42.2M
$74.7M
Q3 25
$44.5M
$76.3M
Q2 25
$41.0M
$80.7M
Q1 25
$40.8M
$79.4M
Q4 24
$41.2M
$79.6M
Q3 24
$38.1M
$76.4M
Q2 24
$38.0M
$75.9M
Net Profit
FBIZ
FBIZ
HCAT
HCAT
Q1 26
$12.2M
Q4 25
$13.3M
$-91.0M
Q3 25
$14.4M
$-22.2M
Q2 25
$11.4M
$-41.0M
Q1 25
$11.2M
$-23.7M
Q4 24
$14.4M
$-20.7M
Q3 24
$10.5M
$-14.7M
Q2 24
$10.5M
$-13.5M
Gross Margin
FBIZ
FBIZ
HCAT
HCAT
Q1 26
Q4 25
Q3 25
52.6%
Q2 25
Q1 25
Q4 24
Q3 24
47.5%
Q2 24
Operating Margin
FBIZ
FBIZ
HCAT
HCAT
Q1 26
Q4 25
38.5%
-115.3%
Q3 25
39.0%
-22.9%
Q2 25
32.6%
-46.0%
Q1 25
33.0%
-25.4%
Q4 24
37.2%
-22.0%
Q3 24
33.8%
-17.9%
Q2 24
32.6%
-20.8%
Net Margin
FBIZ
FBIZ
HCAT
HCAT
Q1 26
27.5%
Q4 25
31.6%
-121.9%
Q3 25
32.3%
-29.1%
Q2 25
27.8%
-50.8%
Q1 25
27.4%
-29.9%
Q4 24
35.0%
-26.0%
Q3 24
27.6%
-19.3%
Q2 24
27.5%
-17.8%
EPS (diluted)
FBIZ
FBIZ
HCAT
HCAT
Q1 26
$1.44
Q4 25
$1.57
$-1.29
Q3 25
$1.70
$-0.32
Q2 25
$1.35
$-0.59
Q1 25
$1.32
$-0.35
Q4 24
$1.69
$-0.33
Q3 24
$1.24
$-0.24
Q2 24
$1.23
$-0.23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FBIZ
FBIZ
HCAT
HCAT
Cash + ST InvestmentsLiquidity on hand
$265.8M
$95.7M
Total DebtLower is stronger
$153.3M
Stockholders' EquityBook value
$245.8M
Total Assets
$4.3B
$502.6M
Debt / EquityLower = less leverage
0.62×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FBIZ
FBIZ
HCAT
HCAT
Q1 26
$265.8M
Q4 25
$39.5M
$95.7M
Q3 25
$44.3M
$91.5M
Q2 25
$123.2M
$97.3M
Q1 25
$170.6M
$342.0M
Q4 24
$157.7M
$392.0M
Q3 24
$132.0M
$387.3M
Q2 24
$81.1M
$308.3M
Total Debt
FBIZ
FBIZ
HCAT
HCAT
Q1 26
Q4 25
$153.3M
Q3 25
$153.1M
Q2 25
$153.0M
Q1 25
$382.9M
Q4 24
$382.4M
Q3 24
$345.0M
Q2 24
Stockholders' Equity
FBIZ
FBIZ
HCAT
HCAT
Q1 26
Q4 25
$371.6M
$245.8M
Q3 25
$358.3M
$331.9M
Q2 25
$344.8M
$347.5M
Q1 25
$336.1M
$376.8M
Q4 24
$328.6M
$365.2M
Q3 24
$312.0M
$355.0M
Q2 24
$305.2M
$357.0M
Total Assets
FBIZ
FBIZ
HCAT
HCAT
Q1 26
$4.3B
Q4 25
$4.1B
$502.6M
Q3 25
$4.0B
$587.1M
Q2 25
$4.0B
$616.2M
Q1 25
$3.9B
$891.5M
Q4 24
$3.9B
$858.9M
Q3 24
$3.7B
$813.0M
Q2 24
$3.9B
$691.7M
Debt / Equity
FBIZ
FBIZ
HCAT
HCAT
Q1 26
Q4 25
0.62×
Q3 25
0.46×
Q2 25
0.44×
Q1 25
1.02×
Q4 24
1.05×
Q3 24
0.97×
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FBIZ
FBIZ
HCAT
HCAT
Operating Cash FlowLast quarter
$9.9M
Free Cash FlowOCF − Capex
$9.6M
FCF MarginFCF / Revenue
12.9%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-697.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FBIZ
FBIZ
HCAT
HCAT
Q1 26
Q4 25
$61.7M
$9.9M
Q3 25
$18.4M
$-464.0K
Q2 25
$15.8M
$-9.0M
Q1 25
$11.3M
$280.0K
Q4 24
$57.5M
$-3.5M
Q3 24
$13.8M
$6.2M
Q2 24
$13.1M
$1.6M
Free Cash Flow
FBIZ
FBIZ
HCAT
HCAT
Q1 26
Q4 25
$61.1M
$9.6M
Q3 25
$18.3M
$-719.0K
Q2 25
$15.5M
$-9.2M
Q1 25
$11.2M
$-390.0K
Q4 24
$57.3M
$-3.9M
Q3 24
$13.2M
$5.5M
Q2 24
$12.7M
$1.3M
FCF Margin
FBIZ
FBIZ
HCAT
HCAT
Q1 26
Q4 25
144.7%
12.9%
Q3 25
41.0%
-0.9%
Q2 25
37.8%
-11.4%
Q1 25
27.5%
-0.5%
Q4 24
139.2%
-4.9%
Q3 24
34.6%
7.2%
Q2 24
33.3%
1.7%
Capex Intensity
FBIZ
FBIZ
HCAT
HCAT
Q1 26
Q4 25
1.4%
0.4%
Q3 25
0.3%
0.3%
Q2 25
0.8%
0.3%
Q1 25
0.2%
0.8%
Q4 24
0.5%
0.5%
Q3 24
1.6%
0.9%
Q2 24
1.1%
0.4%
Cash Conversion
FBIZ
FBIZ
HCAT
HCAT
Q1 26
Q4 25
4.63×
Q3 25
1.28×
Q2 25
1.39×
Q1 25
1.01×
Q4 24
3.99×
Q3 24
1.31×
Q2 24
1.25×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FBIZ
FBIZ

Segment breakdown not available.

HCAT
HCAT

Recurring Technology$51.9M69%
Professional Services$22.8M31%

Related Comparisons